<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company, BD Biosciences division, valued at $23,172.96 on November 22, 2010, for maintenance and repair of office machines with an ultimate completion date of September 30, 2011. Performance is located in San Jose, California. The order is firm fixed price with no set-aside applied.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for a maintenance agreement valued at $32,562.00, with an award date of February 28, 2019 and completion date of March 14, 2020. Place of performance is San Jose, California. The order is priced on a firm fixed price basis with no small business set-aside.</p>
<p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on October 15, 2010, with a ceiling value of $13,579.92.</p>
<p>The order runs through September 30, 2011, and is priced as firm fixed price with no set-aside applied. Place of performance is Bethesda, MD 20892.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on January 25, 2016, for $88,004.44 to provide maintenance service on LSRFORTESSA equipment with an ultimate completion date of January 31, 2017. Performance occurs in San Jose, California. The order is firm fixed price with no set-aside.</p>
<p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on November 3, 2010, with a ceiling value of $10,689.96 for service contract support through November 15, 2010.</p>
<p>Place of performance is Bethesda, MD. The order was issued on firm fixed price basis with no set-aside. The source does not identify a parent indefinite delivery vehicle or contract number for this order.</p>
The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...
<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company's BD Biosciences division valued at $29,828.40 for maintenance agreement services on a BD Biosciences LSR Fortessa special order system, with an award date of January 7, 2015 and ultimate completion date of January 31, 2016.</p>
<p>Work is performed in Bethesda, Maryland. The purchase order carries firm fixed price terms and no set-aside designation.</p>
The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $29,376.00 on February 10, 2015, with an ultimate completion date of March 14, 2016. The order covers a FACSARIA II special order system maintenance agreement, priced on a firm fixed price basis with no set-aside. Work is performed at Bethesda, Maryland. This is a commercial item procurement for flow cytometry system maintenance, consistent with BD Biosciences'...
<p>The National Heart Lung and Blood Institute issued a purchase order to Becton, Dickinson and Company (Infectious Disease Systems division) on February 28, 2018, with a ceiling value of $32,562.00 for maintenance services. The order is firm fixed price with no small business set-aside. Place of performance is Bethesda, Maryland. The ultimate completion date is March 14, 2019.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company for $142,981.11 on March 27, 2013, for service on an LSR II Special flow cytometer system (no lasers). Performance is located in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of April 2, 2018.</p>